Early insights into the impact of an ambient AI scribe solution on clinical documentation to reduce clinician burnout in oncology.

5/28/2025 • Journal of Clinical Oncology • License: CC BY

Chow, R.

Abstract

An early study on the use of ambient AI scribes in oncology found the technology to be feasible and acceptable to clinicians. 94% of respondents used the AI-drafted content, and 61% expressed a desire for continued access. 44% reported a reduction in time spent documenting after clinic hours. The findings support further investment and larger-scale studies to assess the technology's impact on workflow efficiency and provider satisfaction in the complex oncology setting.

Source: View original

Clinical implications

In a preliminary study within oncology, an ambient AI scribe was found to be a feasible and well-received tool for reducing documentation burden. A notable portion of clinicians reported spending less time on notes after hours, suggesting a positive impact on work-life balance.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. Links to third-party publications are provided for research discovery.